Comparing The Veress Needle With Alternative Access Techniques And Future Prospects

https://en.wikipedia.org/wiki/Veress_needle

In the realm of laparoscopic access, the Veress needle is not the only option. It competes with direct trocar entry, optical trocars, the open Hasson technique, and the recently popularized transumbilical single-incision laparoscopy (SILS). Each method has distinct advantages and disadvantages. Yet, owing to its long history and versatility, the Veress needle retains a dominant position.

Direct trocar entry​ omits the step of pre-insufflation, entering the abdomen in a single motion, theoretically shortening operative time. However, lacking the spring-protected mechanism of the Veress needle, the risk of injury-particularly for novices-is significantly higher. Optical trocars​ utilize a transparent tip and camera to provide real-time visualization of tissue layers, but they are costly and require additional equipment. While the open technique​ is arguably the safest, it necessitates a larger incision, contradicting the minimally invasive ethos.

In comparison, the Veress needle offers four key advantages:

1. Simplicity:​ It requires no complex power source or light source.
2. Low Cost:​ Disposable versions cost roughly one-tenth of optical trocar sets.
3. Speed:​ An experienced surgeon can complete insufflation in under 30 seconds.
4. Versatility:​ It is suitable for patients ranging from neonates to the elderly.

Its primary disadvantage lies in the high degree of tactile feedback required from the operator, coupled with a higher failure rate in patients with adhesions.

Interestingly, these methods are not mutually exclusive. Clinicians frequently adopt hybrid strategies: for instance, using the Veress needle to establish a low-pressure pneumoperitoneum (8–10 mmHg), followed by the insertion of an optical trocar under direct visualization to enlarge the port. Alternatively, after an open approach, a Veress needle may be used to assist with insufflation to minimize gas leakage. This "hybrid" thinking reflects a philosophy of pragmatism.

Future Developments

The evolution of the Veress needle is heading in three primary directions:

1. Miniaturization and Integration:​ Research is underway to combine the Veress needle with energy devices, granting it hemostatic capabilities to reduce bleeding at the puncture site.
2. Material Innovation:​ Veress needles made of absorbable biomaterials are currently in animal trials, eliminating the need for retrieval and reducing foreign body reactions.
3. Robotic Assistance:​ The da Vinci Surgical System has developed dedicated Veress needle adapters, allowing robotic arms to execute standardized access, eliminating errors caused by hand tremors.

Another notable trend is "Gasless Laparoscopy."​ By using mechanical lifting devices instead of gas insufflation, the complications associated with pneumoperitoneum are completely avoided. In this scenario, the Veress needle's role shifts to that of a simple guide for instrument insertion. However, gasless technology remains immature, often limiting surgical exposure, and is unlikely to replace traditional pneumoperitoneum in the short term.

Market Data

Market statistics confirm the enduring vitality of the Veress needle. Global consumption exceeds 20 million units annually, with a stable CAGR of 4%–6%. The Asia-Pacific region leads in growth due to the rising adoption of minimally invasive surgery. While the influx of generic copies has triggered price competition, it has also led to quality inconsistencies. Consequently, medical institutions must prioritize product certifications (such as CE and FDA) and select reputable brands.

Conclusion

The Veress needle is not poised to exit the historical stage. It continues to reinvent itself through convergence with new technologies, serving millions of laparoscopic procedures worldwide. As one senior surgeon aptly noted: "As long as we need to establish a pneumoperitoneum, the Veress needle will always have a place in the operating room."